NetworkNewsBreaks – Nutriband Inc. (NASDAQ: NTRB
Post# of 48
(Total Views: 154)
Posted On: 05/16/2024 4:41:10 PM
NetworkNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Names Seasoned Business Leader to Board of Directors
Nutriband (NASDAQ: NTRB), a developer of transdermal pharmaceutical solutions, has announced a new member of its board of directors. According to the announcement, Sergei Glinka, a seasoned and highly respected business executive, will serve on the board. An Estonian citizen, Glinka has served in several executive and board roles positions in large European companies, including Automecanica Skb Property Srl., GST Investments OU and TG Biochemicals Ltd. Glinka’s expertise will support and facilitate new licensing and networking opportunities for Nutriband throughout Europe as the company works to expand its AVERSA(TM) technology, which is patented in 45 countries. The announcement noted that Glinka invested $4.5 million in Nutriband through the company’s April $8.4 million private placement; the funds will be used to complete the FDA-approval process for the proprietary AVERSA technology. “We are thrilled to welcome Mr. Glinka to our board and believe his strategic insights and European market expertise will be invaluable as we continue to develop and expand our innovative suite of brands lead by our AVERSA technology,” said Nutriband CEO Gareth Sheridan in the press release.
NOTE TO INVESTORS: The latest news and updates relating to NTRB are available in the company’s newsroom at http://nnw.fm/NTRB
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer
Nutriband (NASDAQ: NTRB), a developer of transdermal pharmaceutical solutions, has announced a new member of its board of directors. According to the announcement, Sergei Glinka, a seasoned and highly respected business executive, will serve on the board. An Estonian citizen, Glinka has served in several executive and board roles positions in large European companies, including Automecanica Skb Property Srl., GST Investments OU and TG Biochemicals Ltd. Glinka’s expertise will support and facilitate new licensing and networking opportunities for Nutriband throughout Europe as the company works to expand its AVERSA(TM) technology, which is patented in 45 countries. The announcement noted that Glinka invested $4.5 million in Nutriband through the company’s April $8.4 million private placement; the funds will be used to complete the FDA-approval process for the proprietary AVERSA technology. “We are thrilled to welcome Mr. Glinka to our board and believe his strategic insights and European market expertise will be invaluable as we continue to develop and expand our innovative suite of brands lead by our AVERSA technology,” said Nutriband CEO Gareth Sheridan in the press release.
NOTE TO INVESTORS: The latest news and updates relating to NTRB are available in the company’s newsroom at http://nnw.fm/NTRB
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer
(0)
(0)